These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27827392)

  • 1. MHC class II complexes sample intermediate states along the peptide exchange pathway.
    Wieczorek M; Sticht J; Stolzenberg S; Günther S; Wehmeyer C; El Habre Z; Álvaro-Benito M; Noé F; Freund C
    Nat Commun; 2016 Nov; 7():13224. PubMed ID: 27827392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
    Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
    J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
    Painter CA; Stern LJ
    Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of peptide repertoire selection by HLA-DM.
    Pos W; Sethi DK; Wucherpfennig KW
    Trends Immunol; 2013 Oct; 34(10):495-501. PubMed ID: 23835076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
    Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
    Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
    Schulze MS; Wucherpfennig KW
    Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes.
    Belmares MP; Busch R; Wucherpfennig KW; McConnell HM; Mellins ED
    J Immunol; 2002 Nov; 169(9):5109-17. PubMed ID: 12391227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.
    Yin L; Trenh P; Guce A; Wieczorek M; Lange S; Sticht J; Jiang W; Bylsma M; Mellins ED; Freund C; Stern LJ
    J Biol Chem; 2014 Aug; 289(34):23449-64. PubMed ID: 25002586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How HLA-DM works: recognition of MHC II conformational heterogeneity.
    Sadegh-Nasseri S; Chou CL; Hartman IZ; Kim A; Narayan K
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1325-32. PubMed ID: 22652874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional HLA-DM on the surface of B cells and immature dendritic cells.
    Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
    EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DM: arbiter conformationis.
    Ferrante A
    Immunology; 2013 Feb; 138(2):85-92. PubMed ID: 23113687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural principles of MHC class II antigen presentation.
    Nelson CA; Fremont DH
    Rev Immunogenet; 1999; 1(1):47-59. PubMed ID: 11256572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange.
    Sant AJ; Beeson C; McFarland B; Cao J; Ceman S; Bryant PW; Wu S
    Immunol Rev; 1999 Dec; 172():239-53. PubMed ID: 10631950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
    Painter CA; Negroni MP; Kellersberger KA; Zavala-Ruiz Z; Evans JE; Stern LJ
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19329-34. PubMed ID: 22084083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
    Mosyak L; Zaller DM; Wiley DC
    Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
    Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
    Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
    Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
    J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.